Composition for the use to treat alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/06 (2006.01) A23L 1/00 (2006.01) A61K 31/12 (2006.01) A61K 31/195 (2006.01) A61K 31/353 (2006.01) A61K 31/385 (2006.01) A61K 31/675 (2006.01) A61K 36/67 (2006.01)

Patent

CA 2745233

Formulations for the prevention and treatment of neurological diseases and cognitive deficiencies, i.e., Alzheimer's Disease (AD), Parkinson's Disease, amyotrophic lateral sclerosis, mild cognitive impairment and other types of dementia, comprise therapeutically effective amounts of curcumin, piperine, epigallocatechin-3- gallate (EGCG) and one or more of N-acetylcysteine, benfotiamine and alpha-lipoic acid. The combination addresses some or all of the pathways which can result in neurological deficiencies, degeneration and diseases.

L'invention porte sur des formulations destinées à la prévention et au traitement de maladies neurologiques et de déficiences cognitives, par exemple la maladie d'Alzheimer (AD), la maladie de Parkinson, la sclérose latérale amyotrophique, le trouble cognitif léger et d'autres types de démences. Les formulations comprennent des quantités thérapeutiquement efficaces de curcumine, de pipérine, d'épigallocatéchine-3-gallate (EGCG) et de l'un ou de plusieurs parmi la N-acétylcystéine, la benfotiamine et l'acide alpha-lipoïque. La combinaison traite certaine ou toutes les voies qui peuvent conduire à des déficiences, à une dégénération et à des maladies neurologiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for the use to treat alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for the use to treat alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the use to treat alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1706384

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.